⌘K

Home/Filings/4/0001247741-04-000018

4//SEC Filing

LIGAND PHARMACEUTICALS INC 4

Accession 0001247741-04-000018

$LGNDCIK 0000886163operating

View on SEC.gov Company Profile

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 3:15 PM ET

Size

14.5 KB

Accession

0001247741-04-000018

Insider Transaction Report

Form 4

Period: 2004-01-12

LIGAND PHARMACEUTICALS INCLGND

CROSS ALEXANDER D

Director

Transactions

Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2004-01-12−2,494→ 0 total
Exercise: $9.21From: 1995-05-24Exp: 2004-05-24→ Common Stock (2,494 underlying)
Exercise/Conversion
Common Stock
2004-01-12$5.81/sh+8,118$47,186→ 24,494 total
Exercise/Conversion
Common Stock
2004-01-12$9.80/sh+5,625$55,125→ 16,376 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2004-01-12−8,118→ 0 total
Exercise: $5.81From: 1996-05-17Exp: 2005-05-17→ Common Stock (8,118 underlying)
Exercise/Conversion
Common Stock
2004-01-12$9.21/sh+2,494$22,971→ 10,751 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2004-01-12−5,625→ 0 total
Exercise: $9.80From: 1995-05-25Exp: 2004-05-25→ Common Stock (5,625 underlying)

Holdings

Common Stock
(indirect: By Trust)
12,001

Footnotes (1)

[F1]The shares were exercised and not sold.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

LIGAND PHARMACEUTICALS INC

CIK 0000886163

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000886163

Filing Metadata

Form type: 4
Filed: Jan 13, 7:00 PM ET
Accepted: Jan 14, 3:15 PM ET
Size: 14.5 KB

View on SEC.gov